End-stage cystic fibrosis: what to measure and what to try?

F. Ratjen (Toronto, Canada)

Source: Annual Congress 2011 - End-stage lung disease in children
Session: End-stage lung disease in children
Session type: Symposium
Number: 1669
Disease area: Paediatric lung diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Ratjen (Toronto, Canada). End-stage cystic fibrosis: what to measure and what to try?. Annual Congress 2011 - End-stage lung disease in children

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Treatment strategies for cystic fibrosis: what's in the pipeline?
Source: Annual Congress 2010 - High-priority questions on airway infections in diseases seen in children and adults
Year: 2010


Tezacaftor-ivacaftor for the treatment of cystic fibrosis: what’s next?
Source: International Congress 2018 – Therapeutic breakthroughs Year in Review
Year: 2018


Does this patient have cystic fibrosis? 
Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session
Year: 2017


Cystic fibrosis related pulmonary disease: more structure than function?
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005

Lung retransplantation in cystic fibrosis (CF). Is it justifiable?
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Cystic fibrosis: paediatric
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Cystic fibrosis: paediatric
Source: ERS Skills Course 2016
Year: 2016

Cystic fibrosis: paediatric
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Cystic fibrosis: paediatric
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014



Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


How useful is the lung ultrasound in cystic fibrosis?
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


What’s new in cystic fibrosis?
Source: International Congress 2018 – Paediatric Year in Review
Year: 2018


Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Indicators of pulmonary exacerbation in adults with cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011



Cystic fibrosis: adult
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Cystic fibrosis: adult
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Cystic fibrosis: adult
Source: ERS Skills Course 2016
Year: 2016